Abbott Laboratories (ABT) FY2025 Annual P&L / Income Statement

Abbott Laboratories (ABT) FY2025 Annual P&L / Income Statement

Income statement for 2025-01-01 through 2025-12-31. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net Sales

44,328,000,000 US dollars

Cost of products sold, excluding amortization of intangible assets

19,319,000,000 US dollars

Gross profit (calculated)

25,009,000,000 US dollars

Operating expenses (calculated)

16,956,000,000 US dollars

Operating Earnings

8,053,000,000 US dollars

Other income (expense), net (calculated)

413,000,000 US dollars

Earnings before Taxes

8,466,000,000 US dollars

Taxes on Earnings

1,942,000,000 US dollars

Net Earnings

6,524,000,000 US dollars

UNITED STATES

17,126,000,000 US dollars

Non-US

27,202,000,000 US dollars

Amortization of intangible assets

1,682,000,000 US dollars

Research and development

2,942,000,000 US dollars

Selling, general and administrative

12,332,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.